Proteomic Dementia Risk Assessment in Chronic Kidney Disease

Bote Zhao, Zhibo Wang, Yuye Ning, Jianping Jia · 2025

Read Proteomic Dementia Risk Assessment in Chronic Kidney Disease by Bote Zhao, Zhibo Wang, Yuye Ning, Jianping Jia (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714266.txt.

Description

Bote Zhao, Zhibo Wang, Yuye Ning, and Jianping Jia build a blood-based risk tool in 2025 for dementia in people with long-term kidney disease. Kidney disease is common and raises dementia risk on its own. Clinics lack a sharp tool made for this group, the team notes.

They used a large British study with blood protein reads for about three thousand proteins. Their group held 1,355 kidney patients with no dementia at the start. A picked set of seventeen proteins formed the model, trained on 949 people and checked on 406. It beat standard clinic tools, the authors report. Gene-based tests probed whether some proteins might cause, not just mark, the risk. A sharper blood score could steer scarce memory checks to those most at risk.

Catalog record

CREATORBote Zhao, Zhibo Wang, Yuye Ning, Jianping Jia
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11714266

Browse the full library · About the Tower of Babel